Well Counter QC for Bioassay and Wipe Tests

Scintillation well counter QC is the small set of interlocking tests—energy peaking, chi-square constancy, efficiency calibration, background, and minimum detectable activity—that make a department's low-activity measurements trustworthy. The well counter counts wipe tests, I-131 thyroid bioassays, and blood samples, so its QC directly underwrites contamination-control and bioassay compliance. Every one of those tests rests on counting statistics, and every one protects a specific regulatory or clinical decision.

In a nuclear medicine department, the dose calibrator gets most of the quality-control attention because it measures the activity administered to patients. But a second instrument quietly underwrites the radiation safety program: the scintillation well counter. It is the instrument that counts the wipe test proving a hot lab is clean, the thyroid bioassay proving a technologist did not inhale I-131, and the blood sample behind a clearance study.¹ If the well counter is mis-peaked, unstable, or insensitive, those measurements can be wrong in ways that are invisible until an inspection or an incident exposes them.

This guide explains what the well counter does, the QC tests that keep it honest, the counting statistics behind those tests, and how the program supports NRC and Agreement State expectations. DRPS builds and reviews these programs as part of its PET/CT and nuclear medicine physics and radiation safety officer services across Florida, Maryland, Virginia, Washington DC, California, and Nevada.

Introduction

A scintillation well counter is a shielded sodium iodide (NaI(Tl)) detector with a bored-out well, so a small sample is nearly surrounded by the crystal. That geometry gives very high counting efficiency, which is exactly what is needed to measure activities close to background—wipe tests, bioassays, and small research or clearance samples. It measures the opposite end of the activity scale from the dose calibrator: kilobecquerels and below, not the megabecquerels and gigabecquerels of patient dosages.¹

Because the well counter is used to demonstrate regulatory compliance—that removable contamination is below limits, that a worker's thyroid burden is acceptable—its results have to be defensible. That defensibility does not come from the counter reporting a number; it comes from a documented QC program showing the counter was peaked, stable, calibrated, and sensitive enough for the measurement on the day the measurement was made.¹²

This article covers the well counter's role, the core QC tests and their frequencies, the counting-statistics math that underlies constancy and detectability, the clinical and compliance impact, practical tips, and the regulatory framework that makes the program necessary.

Topic Explanation

What does the well counter measure, and why is QC different?

The well counter's job is to convert a very small number of detected photons into a defensible activity or a defensible "below detection limit." Because the activities are low, the measurement is dominated by counting statistics and by the counter's own background—two factors that barely matter for a dose calibrator but dominate here.¹³

Typical well counter uses include:

Wipe tests (removable contamination surveys). Swabs from the hot lab, injection areas, and package surfaces are counted to show removable contamination is below limits, often expressed in disintegrations per minute per 100 cm². See our guide to package receipt and wipe testing.
Radiobioassay. I-131 thyroid bioassays for workers handling radioiodine are counted against a calibrated neck-phantom standard; see thyroid bioassay for I-131 workers.
Blood and urine samples. Plasma volume, red-cell mass, and glomerular filtration studies count timed samples of known volume.
Radiochemical and elution samples. Low-activity aliquots support QC such as radiochemical purity by TLC.

Each of these is a quantitative measurement or a detection decision, and each depends on the counter being properly set up. That is what the QC program verifies.

The core well counter QC tests

QC test	What it verifies	Typical frequency	Action if it fails
Energy peaking (calibration)	Analyzer window centered on the radionuclide photopeak	Each day of use; per radionuclide	Re-peak; investigate gain/high-voltage drift
Constancy (reference source)	Day-to-day reproducibility vs. a decay-corrected long-lived source	Each day of use	Investigate before quantitative counting
Chi-square test	Counting is statistically well-behaved (Poisson)	Periodic (e.g., quarterly)	Investigate electronics, source, contamination
Energy resolution	Detector/PMT health (photopeak FWHM)	Periodic / annually	Service detector if degraded
Efficiency (sensitivity)	Counts per decay for each radionuclide counted	At least annually and after repair	Recalibrate before reporting activity
Background	Baseline counts with no sample	Each day and per counting session	Decontaminate; shield; investigate
Minimum detectable activity	Smallest activity distinguishable from background	With efficiency/background updates	Increase count time or lower background

Peaking and constancy are the daily backbone. Chi-square and energy resolution are periodic health checks. Efficiency, background, and MDA are the trio that turn raw counts into a defensible activity or a defensible detection limit.¹²

Key Technical Principles

Counting statistics: everything starts with Poisson

Radioactive decay is a random process, so a repeated count of the same source will not give the same number twice. The number of counts $N$ in a fixed interval follows Poisson statistics, for which the standard deviation is:

σ = N

The fractional (relative) uncertainty therefore improves only as the square root of the counts:

\frac{σ}{N} = \frac{1}{N}

This single relationship drives well counter practice. To achieve a 1% counting uncertainty you must accumulate $N = 10, 000$ counts; for 10% you need only $N = 100$ . Low-activity samples reach few counts, so the count time (or the efficiency) must be long enough to make the statistical uncertainty acceptable for the decision being made.³⁴

The chi-square test for constancy of behavior

The chi-square test asks a subtle question: does the counter's scatter match what Poisson statistics predict? Take $n$ repeated counts $C_{i}$ of a fixed long-lived source, compute the mean $\overset{ˉ}{C}$ , and form:

χ^{2} = \frac{\sum _{i = 1}^{n} ( C _{i} - C ˉ ) ^{2}}{C ˉ}

For a well-behaved counter, $χ^{2}$ should fall near its expected value of $n - 1$ degrees of freedom. A common acceptance window keeps the corresponding probability roughly between 0.05 and 0.95. A value that is too high means excess scatter—instability, intermittent noise, or a loose source—while a value that is too low means suspiciously little scatter, which can indicate a stuck reading or a non-random artifact. Either extreme is a reason to investigate before trusting quantitative results.¹³ For example, with $n = 10$ measurements ( $n - 1 = 9$ degrees of freedom), a $χ^{2}$ well outside roughly 3.3 to 16.9 falls outside that central probability band and warrants a closer look.

Efficiency (sensitivity) calibration

To report an activity, the counter must be calibrated for the specific radionuclide, because efficiency depends on photon energy and yield. The counting efficiency $ε$ relates the net count rate $R_{net}$ (gross minus background) to the source activity $A$ :

ε = \frac{R _{net}}{A \cdot y}

where $y$ is the photon (gamma) yield per decay for the emission being counted. Well counters achieve high efficiency because the near- $4 π$ geometry surrounds the small sample with crystal, but efficiency still varies strongly with energy and with sample volume and position—so the calibration source should match the geometry of the samples actually counted. Using a Co-57 efficiency to report an I-131 result, or a 1 mL calibration to report a 5 mL sample, introduces error.¹²¹⁰

Minimum detectable activity

For low-level counting, the central question is often not "how much activity?" but "is there any activity at all?" The detectability framework of Currie separates two levels: a critical level for deciding whether a signal is present, and a detection level (the basis of MDA) that accounts for the risk of both false positives and false negatives. A widely used expression for the minimum detectable activity, for a background of $B$ counts accumulated in the same count time $t$ as the sample, is:

MDA = \frac{2.71 + 4.65 B}{ε \cdot y \cdot t}

The constants correspond to a 95% confidence level (5% false-positive and 5% false-negative rates). The practical message is that MDA falls as background drops, as efficiency rises, and as count time lengthens. If a wipe-test or bioassay limit sits below the counter's MDA, then a "not detected" result cannot demonstrate compliance—so the MDA must be established and compared against the applicable action level before the program can rely on negative results.³⁴⁵

Clinical Impact

Well counter QC is where radiation safety compliance is quietly won or lost. A wipe test is only meaningful if the counter that read it was peaked on the right photopeak, calibrated for the right radionuclide, and sensitive enough to see activity below the removable-contamination limit. A department can run wipe tests faithfully every week and still be out of compliance if the counter's MDA is above the limit it is supposed to enforce.¹²

The same logic governs bioassay. For workers handling therapy quantities of I-131, a thyroid bioassay demonstrates that intake stayed within acceptable bounds. That demonstration depends on a well counter (or uptake probe) calibrated against a neck-phantom standard with a decay-corrected reference; an efficiency error or a mis-peaked window can turn a real intake into an apparent "clean" result, or vice versa. See our discussion of thyroid bioassay for I-131 workers and the general treatment of minimum detectable activity in contamination surveys.

Quantitative sample counting—plasma volume, red-cell mass, GFR—feeds directly into clinical results. Because those studies count small, precisely pipetted samples against standards, any drift in efficiency or geometry propagates straight into the reported physiologic value. Well counter QC is therefore not only a radiation-safety instrument but a quantitative-imaging-adjacent measurement whose accuracy has patient-facing consequences.¹

Practical Optimization Tips

A dependable well counter program comes from a few disciplined habits.

1. Peak before you count, every counting day

Detector gain and photomultiplier response drift with temperature and time. Peak the counter on the photopeak of the radionuclide being counted at the start of each counting session, and re-peak when switching radionuclides. A window that has slid off the photopeak silently loses counts and corrupts both efficiency and detectability.¹

2. Use a long-lived, traceable reference for constancy

A long-lived source such as Cs-137 (about 30-year half-life) or Co-57 makes a stable constancy reference; decay-correct it and trend the daily reading. A constancy reading drifting outside the expected band is an early warning of gain or high-voltage problems before they show up as wrong sample results.¹²

3. Match the calibration geometry to the sample

Efficiency depends on sample volume and position in the well. Calibrate with a standard that matches the volume and container of the actual samples, and keep the counting geometry consistent. A geometry mismatch is one of the most common and most overlooked well counter errors.¹

4. Control and monitor background

Background comes from natural radioactivity, nearby sources, and—critically—contamination of the well itself. Measure background each session, keep hot samples away from the counter, use disposable liners, and check for well contamination whenever background rises. Rising background directly worsens MDA.³

5. Establish and post the MDA for each measurement

Compute the MDA for each radionuclide and count time you actually use, and confirm it is below the relevant wipe-test or bioassay action level. If it is not, lengthen the count time or reduce background until it is. Document the MDA so a "not detected" result is defensible.³⁵

Common pitfalls to avoid

Counting off-peak. A mis-peaked window undercounts and invalidates efficiency and MDA.
Using one efficiency for every radionuclide. Efficiency is energy- and yield-specific; each radionuclide needs its own calibration.¹
Ignoring geometry. Volume and position changes shift efficiency; match the calibration to the sample.
Assuming "not detected" means compliant. Without a known MDA below the limit, a negative result proves nothing.⁵
Letting background creep. A contaminated well raises MDA and can create false positives; monitor it.
Skipping chi-square. Constancy alone can look fine while the counting behavior is statistically abnormal.¹³

Regulatory Considerations

The NRC does not publish a single well counter QC checklist, but it requires that measurements used to show compliance be made with operable, appropriately calibrated, and adequately sensitive instruments. A documented well counter QC program is how a licensee meets that expectation for its low-activity measurements.

Key frameworks:

10 CFR Part 20 — Standards for Protection Against Radiation. Surveys reasonable to evaluate radiation levels and concentrations, including removable-contamination wipe tests, must be performed with instruments and methods appropriate for the radiation being measured. The well counter is often the instrument that makes those wipe-test measurements meaningful.⁶
10 CFR Part 35 — Medical Use of Byproduct Material, together with NRC NUREG-1556, Volume 9 licensing guidance, frames expectations for a medical-use program, including bioassay for workers handling therapy quantities of radioiodine, which relies on calibrated low-level counting.⁷⁸
Instrument calibration and QA guidance — IAEA-TECDOC-602 and IAEA Technical Reports Series No. 454 describe QA for nuclear medicine instrumentation and radioactivity measurement, including the peaking, constancy, efficiency, and statistical checks summarized here.²⁹

Agreement States administer parallel programs. Of the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey are NRC Agreement States that license medical use of byproduct material under their own rules, while Washington DC and Delaware are regulated directly by the NRC. A facility should confirm which authority issues its license and whether its license conditions or state rules specify survey-instrument and bioassay requirements. For the broader compliance picture, see reporting radiation incidents to the NRC and survey meter calibration programs. DRPS provides radiation safety officer and medical physicist consulting support to keep these programs documented and defensible.

Frequently Asked Questions (FAQs)

What is a scintillation well counter used for in nuclear medicine?

A scintillation well counter is a shielded sodium iodide detector with a bored-out well that surrounds a small sample, giving very high counting efficiency for low activities. It is used to count wipe tests for removable contamination, radiobioassay samples such as I-131 thyroid bioassays, blood and urine samples for clearance or volume studies, and radiochemical purity or elution samples. It measures activities far too small for a dose calibrator.

How is a well counter different from a dose calibrator?

A dose calibrator is a pressurized ionization chamber that measures relatively high activities, in the megabecquerel-to-gigabecquerel range, for patient dosages. A well counter is a scintillation detector that measures very low activities, from background up to roughly the kilobecquerel range, for wipe tests and bioassays. They serve opposite ends of the activity scale and have separate quality control programs.

What quality control tests does a well counter need?

The core well counter QC tests are energy calibration (peaking) to center the analyzer window on the photopeak, a daily constancy check with a long-lived reference source, a periodic chi-square test to confirm the counting is statistically well-behaved, an efficiency (sensitivity) calibration for each radionuclide counted, a background measurement, and a determination of minimum detectable activity. Energy resolution is also checked as an indicator of detector health.

What is the chi-square test on a well counter?

The chi-square test takes a series of repeated counts of a fixed long-lived source and checks whether their scatter matches what Poisson counting statistics predict. Too little scatter can indicate a stuck or spuriously stable reading; too much scatter indicates instability or electronic noise. A chi-square value outside the acceptable range for the number of measurements is a signal to investigate before trusting quantitative results.

What is minimum detectable activity and why does it matter?

Minimum detectable activity (MDA) is the smallest activity a counter can reliably distinguish from background for a given count time, efficiency, and confidence level. It matters because wipe-test and bioassay limits are only meaningful if the counter can actually detect activity below the limit. If the MDA is higher than the regulatory action level, a "not detected" result does not prove compliance.

How often should well counter QC be performed?

Energy peaking and a constancy (reference-source) check are typically performed each day of use. The chi-square test and background are commonly performed on a periodic schedule such as quarterly, and efficiency is calibrated at least annually and after any repair, source change, or window adjustment. Follow the intervals in your radioactive material license, manufacturer guidance, and applicable NRC or Agreement State requirements.

Does the NRC require well counter quality control?

The NRC does not prescribe a single well counter QC checklist, but it requires that surveys and measurements used to demonstrate compliance—such as contamination wipe tests under 10 CFR Part 20 and bioassays referenced in medical-use licensing guidance—be made with instruments that are operable and appropriately calibrated and sensitive for the measurement. A documented well counter QC program is how a licensee demonstrates that its low-activity measurements are defensible.

Key Takeaways

The well counter underwrites low-activity compliance. Wipe tests, I-131 bioassays, and clearance samples all depend on it, at the opposite end of the activity scale from the dose calibrator.¹
Peaking and constancy are the daily backbone. A window that has slid off the photopeak silently corrupts efficiency and detectability.¹
Counting statistics set the limits. With $σ = N$ , relative uncertainty improves only as $1/ N$ , so count time and efficiency must be matched to the decision.³
Chi-square checks behavior, not just level. It flags counting that is statistically abnormal even when the mean looks acceptable.¹³
MDA makes "not detected" meaningful. A negative wipe test or bioassay proves compliance only when the MDA is demonstrably below the action level.³⁵
Match efficiency to radionuclide and geometry. Energy-, volume-, and position-specific calibration is essential to a defensible activity.¹²

Conclusion

The scintillation well counter rarely gets the attention the dose calibrator does, but it is the instrument standing behind a department's most consequential radiation-safety statements: this surface is clean, this worker's intake was acceptable, this sample is below the limit. Those statements are only as good as the counter's QC. Energy peaking and constancy keep it aligned and stable day to day; chi-square confirms it behaves the way counting statistics say it should; efficiency, background, and MDA turn raw counts into a defensible activity or a defensible detection limit. Built and documented that way, the well counter program lets a licensee stand behind every low-activity number it reports—during routine operations and during an inspection.

How DRPS Can Help

Diagnostic Radiation Physics Services helps nuclear medicine and radiopharmacy programs build well counter QC that is both correct and defensible: peaking and constancy procedures, chi-square and energy-resolution checks, radionuclide- and geometry-specific efficiency calibration, background control, and documented minimum detectable activity tied to the facility's wipe-test and bioassay action levels. This work is delivered as part of PET/CT and nuclear medicine physics, radiation safety officer, and medical physicist consulting support by board-certified medical physicists.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware. A strong well counter program means that when a report says "below the limit," the number behind it can be trusted.

Related Resources

References

Zanzonico P. Routine quality control of clinical nuclear medicine instrumentation: a brief review. Journal of Nuclear Medicine. 2008;49(7):1114-1131. doi:10.2967/jnumed.107.050203. PubMed
International Atomic Energy Agency. Quality Control of Nuclear Medicine Instruments 1991. IAEA-TECDOC-602. Vienna: IAEA; 1991. iaea.org
Knoll GF. Radiation Detection and Measurement. 4th ed. Hoboken, NJ: John Wiley & Sons; 2010. wiley.com
Currie LA. Limits for qualitative detection and quantitative determination: application to radiochemistry. Analytical Chemistry. 1968;40(3):586-593. doi:10.1021/ac60259a007. doi.org
National Council on Radiation Protection and Measurements. A Handbook of Radioactivity Measurements Procedures. NCRP Report No. 58. 2nd ed. Bethesda, MD: NCRP; 1985. ncrponline.org
U.S. Nuclear Regulatory Commission. 10 CFR Part 20: Standards for Protection Against Radiation. nrc.gov
U.S. Nuclear Regulatory Commission. 10 CFR Part 35: Medical Use of Byproduct Material. nrc.gov
U.S. Nuclear Regulatory Commission. NUREG-1556, Volume 9, Revision 3: Program-Specific Guidance About Medical Use Licenses. nrc.gov
International Atomic Energy Agency. Quality Assurance for Radioactivity Measurement in Nuclear Medicine. Technical Reports Series No. 454. Vienna: IAEA; 2006. iaea.org
Cherry SR, Sorenson JA, Phelps ME. Physics in Nuclear Medicine. 4th ed. Philadelphia, PA: Elsevier Saunders; 2012. elsevier.com